查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1892084

2025-2030年針對心理和情緒健康的功能性成分市場成長機會

Growth Opportunities in Functional Ingredients Targeting Mental and Emotional Well-Being, 2025-2030
出版日期: | 出版商: Frost & Sullivan | 英文 52 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

推動心理和情緒健康未來發展的創新策略

本研究深入檢驗了旨在改善心理和情緒健康的新型功能性成分，並對2030年前的成長要素、技術創新和市場機會進行了全面分析。精神疾病仍然是一項重大的全球性挑戰，焦慮症和憂鬱症影響著全球超過10億人。這表明人們對有效、按需且可常規獲得的干涉措施的需求日益成長。目前，藥物治療方法、數位療法和新型人工智慧驅動的個人化護理模式正在不斷創新，天然植物療法和補充劑也正進入市場以填補治療空白。小分子藥物、注射、數位治療和監測工具以及促智製劑的整合正在推動心理健康和情緒健康治療領域的成長和創新。企業和雇主對員工心理健康的投入，以及不斷變化的監管要求，正在推動市場機會。儘管勞動力、社會污名和就醫途徑方面仍然存在挑戰，但精準精神病學以及技術驅動的、基於人工智慧的心理健康診斷和監測預示著未來治療效果的改善。最後，該報告檢驗了競爭格局、資金籌措、夥伴關係和新療法，為對不斷發展的心理健康和情緒健康領域感興趣的相關人員提供了有用的指導。

目錄

策略要務

  • 為什麼經濟成長變得越來越困難？
  • The Strategic Imperative 8
  • 三大策略要務對針對心理和情緒健康的活性成分的影響
  • 成長引擎由成長機會驅動
  • 調查方法

成長機會分析

  • 分析範圍
  • 分割

成長促進因素

  • 成長要素
  • 成長限制因素

心理健康和情緒健康的新興療法

  • 心理健康與情緒福祉：現況與挑戰
  • 心理健康和情緒健康的影響
  • 心理健康照護策略
  • 加速心理健康心理治療
  • 加速在精神健康領域使用小分子藥物、注射劑和舌下膜劑
  • 加速利用數位工具、人工智慧和虛擬實境技術促進心理健康
  • 加速心理健康遠端醫療
  • 加速益智藥對心理健康的益處
  • 歐洲和美國當前的心理健康狀況
  • 亞太和中東地區的心理健康狀況
  • 心理健康產業發展面臨的挑戰

創新現況：心理健康與情緒健康臨床研發管線概述

  • 藥物介入對心理健康的影響
  • 藥物介入促進心理健康—創新者簡介

資金籌措、合作關係和收購

  • 資金籌措分析
  • 重要合作夥伴關係和收購

前景

  • 個人化情緒調節成分－視角
  • 生物活性植物化合物與適應原在壓力管理的興起－一個視角
  • 拓展功能性營養品市場，提升心理健康益處－展望

心理和情緒健康方面的成長機會領域

  • 成長機會 1：處方數位療法 (PDT)
  • 成長機會2：企業對心理健康領域的投資
  • 成長機會 3：擴展與個人化自我護理生態系統

未來發展

  • 成長機會帶來的益處和影響
  • 未來計劃
  • 免責聲明
簡介目錄
Product Code: DB4E

Innovative Strategies Driving the Future of Mental and Emotional Well-Being

The study presents an in-depth exploration of novel functional ingredients designed to enhance mental and emotional well-being, identifying the overall drivers of growth, technological change, and market opportunities through 2030. Mental health disorders continue to present a serious global challenge, with anxiety and depression affecting more than 1 billion individuals worldwide. This indicates only intensifying demand for interventions that are both effective and can be employed on demand and routinely. Innovation is now occurring in pharmacological therapies, digital therapeutics, new AI-driven personalized care models, and natural botanical therapies and supplements are entering the marketplace to address therapy gaps. The incorporation of small molecules, injectables, digital therapeutics and monitoring tools, and nootropic formulations is driving growth and innovation in the treatment of mental health and emotional well-being. Corporate- and employer-branded investments in employee mental well-being, along with changing regulatory requirements, will contribute to the market opportunity. While some challenges remain related to workforce, stigma, and access, precision psychiatry and technology-driven AI-based mental health diagnostics and monitoring can indicate better future outcomes. Lastly, the report will examine the competitive landscape, funding, partnerships, and new therapies to provide useful directions for stakeholders interested in the expanding mental health and emotional well-being space.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on Functional Ingredients Targeting Mental and Emotional Well-Being
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Emerging Therapies to Address Mental Health and Emotional Well-Being

  • Mental Health and Emotional Well-Being: Facts and Challenges
  • Impact of Mental Health and Emotional Well-Being
  • Mental Health Care Strategies
  • Accelerating Psychotherapies for Mental Health
  • Accelerating Small Molecule/Injectables/Sublingual Films for Mental Health
  • Accelerating Digital Tools/AI/VR for Mental Health
  • Accelerating Telemedicine for Mental Health
  • Accelerating Nootropics for Mental Health
  • The Mental Health Landscape in Europe and the United States
  • The Mental Health Landscape in APAC and the Middle East
  • Challenges in Advancing the Mental Health Industry

Innovation Landscape: Clinical Pipeline Overview for Mental Health and Emotional Well-Being

  • Pharmacological Interventions for Mental Well-Being
  • Pharmacological Interventions for Mental Well-Being-Innovator Profiles

Funding, Partnerships, and Acquisitions

  • Funding Analysis
  • Key Partnerships and Acquisitions

Outlook

  • Personalized Formulation of Mood-Enhancing Ingredients-Outlook
  • Rise of Bioactive Botanicals and Adaptogens for Stress-Outlook
  • Growing Market for Functional Nutrition with Mental Health Benefits-Outlook

Growth Opportunity Universe for Mental and Emotional Well-Being

  • Growth Opportunity 1: Prescription Digital Therapeutics PDTs
  • Growth Opportunity 2: Corporate Mental Health Investment
  • Growth Opportunity 3: Expansion and Personalization of Self-Care Ecosystems

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer